Early ultrasonography role by Contrast enhanced ultrasonography ( CEUS) evaluating therapy effectiveness in patients with hepatic metastasis of colorectal cancer treated with antiangiogenetic drug. - ND

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点开始时间: 2007年6月13日最近更新: 2014年2月24日

适应症

试验速览

暂无简介。

•1. Age > 18 years 2. Hystologicaly of colorectal adenocarcinoma 3. Not resectable hepatic metastasis 4. Diameter lesions > 5 millimeters ( at least one lesion) 5. Not preceding chemotherapy for metastatic disease. 6. Signed informed consent
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•A)Patients with contraindications to use of Sonovue 1. Recent Cardiac infarction and frequent and/or several angina cordis events or thoracic ache. 2. Recent surgery upon the coronary arteries 3. Recent electrocardiogram abnormalities 4. Frequent and/or several angina cordis events or thoracic ache in the latest week 5. Cardiac Failure ; severe arhythmia; cardiac right-to-left shunt 6. Serious pulmonary artery hypertension; not controlled arterial hypertension 7. Adult respiratory distress syndrome

发起方

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI